Many commonly used systemic drugs have been linked to retinopathy and other significant ophthalmic problems. Here's an update on ocular toxicology. Congress Tackles the Beast. Medicare is raising its enormous head again as Congress discusses a new prescription drug benefit and the program's reform. Here's what these changes could mean for you and your patients.
Hormone supplements lower risk of cataracts.
Profit from Pillar Point. Morning Rounds Stumbling into a diagnosis. Journal Highlights Preview the October and November issues of Ophthalmology and other journals. Washington Report Academy plays role in new legislation for low vision care. Outlook A giant step toward global guidelines for quality.